The Korean Journal of Gastroenterology :eISSN 2233-6869 / pISSN 1598-9992

 

Table. 3.

TTE Parameters in NAFL versus NASH without and with Type 2 Diabetes

Outcome No type 2 diabetes Type 2 diabetes


NAFL (n=14) NASH (n=7) p-value NAFL (n=3) NASH (n=9) p-value
LVEF (%) 63.3±6.2 65.3±6.2 0.50 56.3±14.0 63.6±6.8 0.64
LV mass index (by BSA, g/m2) 77.4±17.4 79.1±18.8 0.50 98.8±16.4 84.7±21.6 0.23
E/A ratio 1.3±0.5 1.2±0.9 1.00 1.1±0.4 1.0±0.3 0.93
E/e’ ratio 8.6±2.0 11.8±3.1 0.01 9.7±2.6 11.8±3.5 0.31
LA volume index (by BSA, mL/m3) 18.1±5.5 21.0±5.2 0.35 28.0±10.9 25.4±8.0 0.52
TR Velocity (cm/s) 2.1±0.6 (n=7) 2.3±0.3 (n=5) 0.87 2.7 (n=1) 2.6±0.3 (n=3) 0.65
Estimated PASP (mmHg) 25.6±7.9 (n=7) 21.0±11.4 (n=5) 0.63 N/A (n=0) 34.3±10.1 (n=3) N/A
Average Strain (%) -17.1±2.5 -19.4±3.8 0.20 -18.0±3.5 -17.5±3.3 0.78

Values are presented as mean±standard deviation.

TTE, transthoracic echocardiogram; NAFL, nonalcoholic fatty liver; NASH, nonalcoholic steatohepatitis; LVEF, left ventricular ejection fraction; LV, left ventricular; BSA, body surface area; LA, left atrial; TR, tricuspid regurgitation; PASP, pulmonary artery systolic pressure.

Korean J Gastroenterol 2021;78:161~167 https://doi.org/10.4166/kjg.2021.040
© Korean J Gastroenterol